{"id":1830,"date":"2020-04-01T11:35:52","date_gmt":"2020-04-01T11:35:52","guid":{"rendered":"http:\/\/novalab.bold-themes.com\/main-demo\/?page_id=1830"},"modified":"2026-01-25T14:51:15","modified_gmt":"2026-01-25T14:51:15","slug":"management","status":"publish","type":"page","link":"https:\/\/jfpharmaconsulting.com\/de\/about-us\/management\/","title":{"rendered":"Gesch\u00e4ftsf\u00fchrung"},"content":{"rendered":"

<\/div><\/div>
<\/div>

Gesch\u00e4ftsf\u00fchrung<\/span><\/span><\/h1><\/header>
<\/div><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>
\"bt_bb_section_bottom_section_coverage_image\"<\/div><\/section>
<\/div><\/div><\/div>
<\/div>

Chief Executive Officer (CEO)<\/span>Jodie Fernandes

\n<\/span><\/span><\/h2>
BSc, Biomedical Sciences, University of Brighton<\/div><\/header>
<\/div>
<\/p>\n
Jodie Fernandes is the founder and CEO of JF Pharma Consulting Ltd, a leading pharmaceutical company specializing in Cholinesterase inhibitors for neurological conditions, including Alzheimer\u2019s disease, Parkinson\u2019s dementia, and Lewy body dementia. With over 15 years of experience in the pharmaceutical sector, Jodie combines scientific expertise with strategic leadership, guiding the company\u2019s vision and innovation.<\/div>\n
\u00a0<\/div>\n
Her career began as a Senior Microbiologist and Senior Chemist at PQAS, where she developed a strong foundation in laboratory practices and regulatory compliance. She later served as Head of Quality at Auden McKenzie Group, overseeing pharmaceutical quality standards and ensuring product safety. In 2010, Jodie founded JF Pharma Consulting to bring cutting-edge neurological treatments to market. Under her leadership, the company has grown into a trusted and innovative partner in drug development, known for its rigorous scientific approach and commitment to patient care.<\/div>\n

\n<\/div>

<\/div>
<\/div>
<\/div>
<\/div>
<\/div>
<\/div><\/div><\/div><\/div>
<\/div>
<\/div><\/div><\/div><\/div>
<\/div>
<\/div><\/div><\/div><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>
<\/div>

Chief Financial Officer (CFO)<\/span>Alexander Brooks<\/span><\/span><\/h4>
MSc, Finance, London Business School; BSc, Economics, University of Warwick<\/div><\/header>
<\/div>
<\/p>\n
Alexander Brooks is the Chief Financial Officer of JF Pharma Consulting Ltd, responsible for all financial operations, including budgeting, financial planning, risk management, and investment strategy. With a strong background in corporate finance, Alexander ensures the company maintains financial stability while supporting long-term growth and innovation.<\/div>\n
\u00a0<\/div>\n
Before joining JF Pharma Consulting, Alexander worked at leading financial institutions, gaining extensive experience in mergers and acquisitions, financial modeling, and strategic planning. His expertise allows the company to make informed investment decisions and efficiently allocate resources, particularly toward research and development. Alexander\u2019s financial leadership has been instrumental in enabling JF Pharma Consulting to scale operations while continuing to innovate in the field of neurological therapeutics.<\/div>\n

\n<\/div>

<\/div>
\"https:\/\/jfpharmaconsulting.com\/wp-content\/uploads\/2020\/04\/signature.png\"<\/span><\/div>
<\/div><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>
<\/div><\/div><\/div>
<\/div>

Chief Operating Officer (COO)<\/span>Sophia Patel<\/span><\/span><\/h3>
MBA, Harvard Business School; BEng, Chemical Engineering, Imperial College London<\/div><\/header>
<\/div>
<\/p>\n
Sophia Patel serves as the Chief Operating Officer, overseeing the day-to-day operations of JF Pharma Consulting Ltd. She ensures that production, supply chain management, and operational processes run efficiently and adhere to the highest standards of quality and regulatory compliance.<\/div>\n
\u00a0<\/div>\n
Sophia started her career as a chemical engineer and quickly advanced to leadership roles in pharmaceutical operations, focusing on optimizing manufacturing processes and operational efficiency. Her MBA from Harvard Business School complements her technical expertise, giving her the ability to align operational strategy with the company\u2019s broader business goals. Under Sophia\u2019s leadership, JF Pharma Consulting has streamlined production, improved scalability, and maintained consistent quality in its development of Cholinesterase inhibitors, ensuring that patients receive safe, effective, and timely treatments.<\/div>\n

\n<\/div>

<\/div>
<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>
<\/div>

Chief Technology Officer (CTO)<\/span>Dr. Charles Montgomery<\/span><\/span><\/h4>
PhD, Pharmacology, University of Oxford; BSc, Biochemistry, University of Bristol<\/div><\/header>
<\/div>
<\/p>\n
Dr. Charles Montgomery is the Chief Technology Officer at JF Pharma Consulting Ltd, leading research and development initiatives for the company\u2019s neurological therapies. With a PhD in Pharmacology and a strong background in biochemistry, Dr. Montgomery specializes in the design and development of Cholinesterase inhibitors and other advanced therapeutics for neurodegenerative diseases.<\/div>\n
\u00a0<\/div>\n
Prior to joining JF Pharma Consulting, he held senior research roles in top pharmaceutical companies, focusing on drug discovery and translational medicine. He has contributed to numerous scientific publications on neurodegenerative disorders and innovative therapeutic approaches. As CTO, Dr. Montgomery ensures that all products meet rigorous scientific and regulatory standards, advancing treatments that improve patient outcomes worldwide.<\/div>\n

\n<\/div>

<\/div>
\"https:\/\/jfpharmaconsulting.com\/wp-content\/uploads\/2020\/04\/signature.png\"<\/span><\/div>
<\/div><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section><\/p>","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":11,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1830","page","type-page","status-publish","hentry"],"_hostinger_reach_plugin_has_subscription_block":false,"_hostinger_reach_plugin_is_elementor":false,"_links":{"self":[{"href":"https:\/\/jfpharmaconsulting.com\/de\/wp-json\/wp\/v2\/pages\/1830","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jfpharmaconsulting.com\/de\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/jfpharmaconsulting.com\/de\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/jfpharmaconsulting.com\/de\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/jfpharmaconsulting.com\/de\/wp-json\/wp\/v2\/comments?post=1830"}],"version-history":[{"count":21,"href":"https:\/\/jfpharmaconsulting.com\/de\/wp-json\/wp\/v2\/pages\/1830\/revisions"}],"predecessor-version":[{"id":3639,"href":"https:\/\/jfpharmaconsulting.com\/de\/wp-json\/wp\/v2\/pages\/1830\/revisions\/3639"}],"up":[{"embeddable":true,"href":"https:\/\/jfpharmaconsulting.com\/de\/wp-json\/wp\/v2\/pages\/11"}],"wp:attachment":[{"href":"https:\/\/jfpharmaconsulting.com\/de\/wp-json\/wp\/v2\/media?parent=1830"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}